Search images on Google      Product Monograph

Active Ingredients:

• lutetium (177lu) oxodotreotide, 370 MBq/ML

DIN: 02484552

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: SINGLE-DOSE VIAL

Schedule: Schedule C

Company: NOVARTIS PHARMACEUTICALS CANADA INC  –  official site

ATC:

• V10 - THERAPEUTIC RADIOPHARMACEUTICALS (ATC, WHO, Wiki)
• V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS (ATC, WHO)
• V10XX - Various therapeutic radiopharmaceuticals (ATC, WHO)
• V10XX04 - LUTETIUM (177Lu) OXODOTREOTIDE (WHO)

Pharmaceutical standard: MFR

 

External Links for Lutathera:

Search on Google

• Lutathera side effects
• Lutathera dosage
• lutetium side effects
• lutetium dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find lutathera photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.